Contemporary Status of Percutaneous Ablation for the Small Renal Mass

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

Contemporary Status of Percutaneous Ablation for the Small Renal Mass

详细信息查看全文

作者：Benjamin J. Shin ; Jeffrey Forris Beecham Chick…
关键词：Renal cell carcinoma ; Kidney neoplasms ; Renal ablation ; Percutaneous ablation techniques ; Thermal ablation techniques ; Cryoablation
刊名：Current Urology Reports
出版年：2016
出版时间：March 2016
年：2016
卷：17
期：3
全文大小：1,065 KB
参考文献：1.Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009;373(9669):1119–32. doi:S0140-6736(09)60229-4 [pii]10.1016/S0140-6736(09)60229-4
2.Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353(23)):2477. doi:10.1056/NEJMra043172 .CrossRef PubMed
3.Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69. doi:10.3322/caac.20107 .CrossRef PubMed
4.Sahni VA, Silverman SG. Imaging management of incidentally detected small renal masses. Semin Intervent Radiol. 2014;31(1):9. doi:10.1055/s-0033-136383800813 .PubMedCentral CrossRef PubMed
5.Finley DS, Pantuck AJ, Belldegrun AS. Tumor biology and prognostic factors in renal cell carcinoma. Oncologist. 2011;16(2):4. doi:10.1634/theoncologist.2011-S2-04 .PubMedCentral CrossRef PubMed
6.Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349:g4797.PubMedCentral CrossRef PubMed
7.Bakal CW, Cynamon J, Lakritz PS, Sprayregen S. Value of preoperative renal artery embolization in reducing blood transfusion requirements during nephrectomy for renal cell carcinoma. J Vasc Interv Radiol. 1993;4(6):727.CrossRef PubMed
8.Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182((4):1271. doi:10.1016/j.juro.2009.07.004 .CrossRef
9.Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913. doi:10.1016/j.eururo.2015.01.005 .CrossRef PubMed
10.Van Poppel H, Becker F, Cadeddu JA, Gill IS, Janetschek G, Jewett MA, et al. Treatment of localised renal cell carcinoma. Eur Urol. 2011;60(4):662. doi:10.1016/j.eururo.2011.06.040 .CrossRef PubMed
11.Trudeau V, Larcher A, Boehm K, Dell'Oglio P, Sun M, Tian Z. Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: a Population-Based Study. Urology. 2015. doi:10.1016/j.urology.2015.08.043 .PubMed
12.Ogan K, Jacomides L, Dolmatch BL, Rivera FJ, Dellaria MF, Josephs SC, et al. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology. 2002;60(6):954.CrossRef PubMed
13.Escudier B, Porta C, Schmidinger M, Algaba F, Patard JJ, Khoo V. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(3:ii):49. doi:10.1093/annonc/mdu259 .CrossRef
14.••

Tuncali K, van Sonnenberg E, Shankar S, Mortele KJ, Cibas ES, Silverman SG. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. AJR Am J Roentgenol. 2004;18(3):575. doi:10.2214/ajr.183.3.1830575 . A study that highlights the importance of biopsy prior to ablation procedures.CrossRef
15.Schmit GD, Kurup AN, Weisbrod AJ, Thompson RH, Boorjian SA, Wass CT, et al. ABLATE: a renal ablation planning algorithm. AJR Am J Roentgenol. 2014;202(4):894. doi:10.2214/AJR.13.11110 .CrossRef PubMed
16.Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3):844. doi:10.1016/j.juro.2009.05.035 .CrossRef PubMed
17.•

Schmit GD, Thompson RH, Kurup AN, Weisbrod AJ, Boorjian SA, Carter RE. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. J Urol. 2013;89(1):30. doi:10.1016/j.juro.2012.08.180 . A study that introduces the RENAL nephrometry algorithm to predict the outcomes and complications associated with ablation procedures.CrossRef
18.Allen BC, Remer EM. Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging. Radiographics. 2010;30(4):887. doi:10.1148/rg.304095134 .CrossRef PubMed
19.Sahni VA, Silverman SG. Biopsy of renal masses: when and why. Cancer Imaging. 2009;9:44. doi:10.1102/1470-7330.2009.0005 .PubMedCentral CrossRef PubMed
20.Ramanathan R, Leveillee RJ. Ablative therapies for renal tumors. Ther Adv Urol. 2010;2(2):51. doi:10.1177/175628721036670810.1177_1756287210366708 .PubMedCentral CrossRef PubMed
21.Venkatesan AM, Wood BJ, Gervais DA. Percutaneous ablation in the kidney. . 2011;26(2):375. doi:10.1148/radiol.11091207 .
22.Dominguez-Escrig JL, Sahadevan K, Johnson P. Cryoablation for small renal masses. Adv Urol. 2008:479495. doi:10.1155/2008/479495
23.Zagoria RJ. Imaging-guided radiofrequency ablation of renal masses. Radiographics. 2004;24(1):S59. doi:10.1148/rg.24si045512 .CrossRef PubMed
24.Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25(1):S69. doi:10.1148/rg.25si055501 .CrossRef PubMed
25.Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Radiology. 2012;263:900. doi:10.1148/radiol.12111209 .CrossRef PubMed
26.Weizer AZ, Raj GV, O'Connell M, Robertson CN, Nelson RC, Polascik TJ. Complications after percutaneous radiofrequency ablation of renal tumors. Urology. 2005;66(6):1176. doi:10.1016/j.urology.2005.06.125 .CrossRef PubMed
27.Kurup AN. Percutaneous ablation for small renal masses-complications. Semin Intervent Radiol. 2014;31(1):42. doi:10.1055/s-0033-136384200817 .PubMedCentral CrossRef PubMed
28.Bhayani SB, Allaf ME, Su LM, Solomon SB. Neuromuscular complications after percutaneous radiofrequency ablation of renal tumors. Urology. 2005;65(3):592. doi:10.1016/j.urology.2004.09.053 .CrossRef PubMed
29.Higgins LJ, Hong K. Renal ablation techniques: state of the art. AJR Am J Roentgenol. 2015;205(4):735. doi:10.2214/AJR.15.14752 .CrossRef PubMed
30.Siu W, Hafez KS, 3rd Johnston WK, Jr. Wolf JS. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar. Urol Oncol. 2007;25(2):115. doi:10.1016/j.urolonc.2006.07.018 .CrossRef PubMed
31.Iannuccilli JD, Grand DJ, Dupuy DE, Mayo-Smith WW. Percutaneous ablation for small renal masses-imaging follow-up. Semin Intervent Radiol. 2014;31(1):50. doi:10.1055/s-0033-136384300818 .PubMedCentral CrossRef PubMed
32.Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int. 2007;100(2):287. doi:10.1111/j.1464-410X.2007.06937.x .CrossRef PubMed
33.Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA, et al. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol. 2012;61(6):1156. doi:10.1016/j.eururo.2012.01.001 .CrossRef PubMed
34.Chang X, Zhang F, Liu T, Ji C, Zhao X, Yang R. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma: long-term clinical and oncologic outcomes. J Urol. 2015;193(2):430. doi:10.1016/j.juro.2014.07.112 .CrossRef PubMed
35.••Thompson RH, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67(2):252–9. doi:10.1016/j.eururo.2014.07.021 . A study comparing partial nephrectomy to both radiofrequency and cryoablation ablation for cT1 renal masses.CrossRef PubMed
36.Klatte T, Grubmuller B, Waldert M, Weibl P, Remzi M. Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol. 2011;60(3):435. doi:10.1016/j.eururo.2011.05.002 .CrossRef PubMed
37.Aron M, Kamoi K, Remer E, Berger A, Desai M, Gill I, et al. Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol. 2010;183(3):889. doi:10.1016/j.juro.2009.11.041 .CrossRef PubMed
38.•Zargar H, Samarasekera D, Khalifeh A, Remer EM, O'Malley C, Akca O. Laparoscopic vs percutaneous cryoablation for the small renal mass: 15-year experience at a single center. Urology. 2015;85(4):850. doi:10.1016/j.urology.2015.01.004 . A study comparing laparoscopic and cryoablation for small renal masses showing no difference between overall or recurrence-free survival.CrossRef PubMed
39.Goyal J, Verma P, Sidana A, Georgiades CS, Rodriguez R. Single-center comparative oncologic outcomes of surgical and percutaneous cryoablation for treatment of renal tumors. J Endourol. 2012;26(11):1413. doi:10.1089/end.2012.0244 .CrossRef PubMed
40.Moreland AJ, Ziemlewicz TJ, Best SL, Hinshaw JL, Lubner MG, Alexander ML, et al. High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation. J Endourol. 2014;28(9):1046. doi:10.1089/end.2014.0190 .CrossRef PubMed
41.•Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Zhang X. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results. Radiology. 2014;270(3):880. doi:10.1148/radiol.13130275 . A study comparing radical nephrectomy and microwave ablation showing comparable oncologic results for nephrectomy and microwave ablation and no major complications for microwave ablation.CrossRef PubMed
42.Guan W, Bai J, Liu J, Wang S, Zhuang Q, Ye Z, et al. Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results. J Surg Oncol. 2012;106(3):316. doi:10.1002/jso.23071 .CrossRef PubMed

作者单位：Benjamin J. Shin (1)
Jeffrey Forris Beecham Chick (1)
S. William Stavropoulos (2)

1. Department of Radiology, Division of Interventional Radiology, University of Pennsylvania Health System 1 Silverstein, 3400 Spruce Street, Philadelphia, PA, 19104, USA
2. Department of Radiology, Division of Interventional Radiology, Perelman School of Medicine at the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA

刊物主题：Urology/Andrology; Nephrology;

出版者：Springer US

ISSN：1534-6285

文摘

Renal cell carcinoma is the tenth most common malignancy in the USA, with upwards of 61,000 new cases and resulting in more than 14,000 deaths annually. Although partial nephrectomy remains the standard treatment, image-guided nephron-sparing ablative techniques including cryoablation, radiofrequency ablation, and microwave ablation have emerged as treatment options in certain patient populations. Ablative therapies have high technical successes, low tumor recurrence rates, and preserve renal parenchymal volume. The purpose of this article is to provide an update on ablation therapies for small renal masses. Keywords Renal cell carcinoma Kidney neoplasms Renal ablation Percutaneous ablation techniques Thermal ablation techniques Cryoablation